首页> 外文期刊>The pharmaceutical journal >Pharmacy key to reducing antipsychotics in dementia
【24h】

Pharmacy key to reducing antipsychotics in dementia

机译:降低痴呆症抗精神病药物的关键

获取原文
获取原文并翻译 | 示例
           

摘要

PHARMACY is identified as one of eight key professional groups by the Dementia Action Alliance and the NHS Institute for Innovation and Improvement in their "call to action" on the use of antipsychotic drugs for people with dementia.This follows continuing and widespread concern about the over-prescribing of antipsychotics for the condition.The Department of Health's 2009 report on the prescribing on antipsychotic drugs to people with dementia (the Banerjee report), estimated there are 180,000 people with dementia who are currently prescribed antipsychotics and that two thirds of this prescribing is unnecessary (PJ 2009;283:558.Pharmacists can make a vital contribution by working with patients, carers, health and social care teams to reduce inappropriate use of antipsychotics for dementia.
机译:在痴呆症行动联盟和NHS创新与改善研究所就痴呆症患者使用抗精神病药物的“号召性行动”中,PHARMACY被确定为八个主要专业团体之一。 -为该病开具抗精神病药处方。卫生部2009年针对痴呆症患者开具抗精神病药处方的报告(Banerjee报告)估计,目前有18万痴呆症患者正在服用抗精神病药,而该处方的三分之二是(PJ 2009; 283:558。药剂师可以通过与患者,护理人员,保健和社会护理团队合作,以减少不适当地使用抗精神病药治疗痴呆症做出重要贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号